VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,018 | -67.1% | 131,557 | -48.9% | 0.00% | -75.0% |
| Q2 2023 | $6,126 | +107.4% | 257,536 | +121.7% | 0.00% | +300.0% |
| Q1 2023 | $2,954 | +1.8% | 116,143 | +16.9% | 0.00% | 0.0% |
| Q4 2022 | $2,901 | -100.0% | 99,320 | -84.8% | 0.00% | -93.3% |
| Q3 2022 | $13,409,000 | +6225.0% | 653,751 | +3473.4% | 0.02% | – |
| Q2 2022 | $212,000 | -32.5% | 18,295 | +7.6% | 0.00% | – |
| Q1 2022 | $314,000 | – | 17,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $68,684,566 | 13.41% |
| COMMODORE CAPITAL LP | 2,189,659 | $55,704,925 | 8.48% |
| Fairmount Funds Management LLC | 1,369,623 | $34,843,209 | 5.99% |
| Paradigm Biocapital Advisors LP | 2,085,698 | $53,060,157 | 5.03% |
| Octagon Capital Advisors LP | 1,185,000 | $30,146,400 | 4.34% |
| Logos Global Management LP | 950,000 | $24,168,000 | 3.46% |
| TCG Crossover Management, LLC | 663,610 | $16,882,238 | 3.29% |
| ACUTA CAPITAL PARTNERS, LLC | 168,000 | $4,273,920 | 3.15% |
| Vivo Capital, LLC | 1,678,207 | $42,693,586 | 2.96% |
| TANG CAPITAL MANAGEMENT LLC | 692,925 | $17,628,012 | 2.63% |